 |
Фармсинтез
LIFE
|
59.3 B |
- |
- |
- |
Russia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Завод ДИОД
DIOD
|
3.14 B |
- |
- |
- |
Russia |
 |
Aptose Biosciences
APTO
|
36.2 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cleveland BioLabs, Inc.
CBLI
|
-29.8 M |
- |
-7.31 % |
$ 49 M |
USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
880 M |
- |
- |
$ 1.77 B |
USA |
 |
Aravive
ARAV
|
58.2 M |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
5.42 B |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Biofrontera AG
BFRA
|
744 M |
- |
-8.24 % |
$ 105 M |
Germany |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
168 B |
- |
-6.97 % |
$ 657 M |
USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
15.4 B |
- |
1.68 % |
$ 4.65 B |
China |
 |
Flexion Therapeutics, Inc.
FLXN
|
1.49 B |
- |
- |
$ 459 M |
USA |
 |
Heat Biologics, Inc.
HTBX
|
4.26 B |
- |
-5.76 % |
$ 99.8 M |
USA |
 |
Kindred Biosciences, Inc.
KIN
|
20.2 B |
- |
0.11 % |
$ 419 M |
USA |
 |
Shineco, Inc.
TYHT
|
22.9 B |
- |
-3.90 % |
$ 97.2 M |
China |
 |
Millendo Therapeutics, Inc.
MLND
|
31.7 B |
- |
-5.36 % |
$ 20.2 M |
USA |
 |
Progenity, Inc.
PROG
|
225 M |
- |
-3.47 % |
$ 164 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
664 M |
- |
- |
$ 1.2 B |
USA |
 |
Strongbridge Biopharma plc
SBBP
|
32.8 B |
- |
1.52 % |
$ 136 M |
USA |
 |
Decibel Therapeutics
DBTX
|
109 M |
- |
- |
$ 123 M |
USA |
 |
Seneca Biopharma, Inc.
SNCA
|
2.82 B |
- |
-1.19 % |
$ 28.7 M |
USA |
 |
IVERIC bio
ISEE
|
2.62 B |
- |
- |
$ 5.51 B |
USA |
 |
Myovant Sciences Ltd.
MYOV
|
587 M |
- |
-0.04 % |
$ 2.62 B |
USA |
 |
Trean Insurance Group
TIG
|
1.47 B |
- |
- |
$ 316 M |
USA |
 |
Virpax Pharmaceuticals
VRPX
|
1.81 M |
- |
-45.12 % |
$ 2.85 M |
USA |
 |
Metacrine
MTCR
|
-35.4 M |
- |
- |
$ 24.2 M |
USA |
 |
Celsion Corporation
CLSN
|
-3.55 M |
- |
-6.63 % |
$ 13.9 M |
USA |
 |
I-Mab
IMAB
|
127 M |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B |
- |
- |
$ 40.3 B |
USA |
 |
AnaptysBio
ANAB
|
1.28 B |
$ 56.8 |
0.94 % |
$ 1.63 B |
USA |
 |
Genfit SA
GNFT
|
168 B |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
174 M |
- |
-13.47 % |
$ 169 M |
France |
 |
CureVac N.V.
CVAC
|
-376 M |
- |
- |
$ 867 M |
Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
5.18 B |
- |
- |
$ 4.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
-1.76 M |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
MorphoSys AG
MOR
|
2.44 B |
- |
2.43 % |
$ 254 M |
Germany |
 |
Affimed N.V.
AFMD
|
-38.5 M |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
215 M |
- |
-1.58 % |
$ 28.1 M |
China |
 |
Celyad Oncology SA
CYAD
|
-1.83 M |
- |
- |
$ 12.5 M |
Belgium |
 |
Gracell Biotechnologies
GRCL
|
-1.17 B |
- |
- |
$ 3.37 B |
China |
 |
Galapagos NV
GLPG
|
1.99 B |
- |
- |
$ 1.83 B |
Belgium |
 |
Teligent, Inc.
TLGT
|
4.75 B |
- |
-13.85 % |
$ 16.1 M |
USA |
 |
Viela Bio, Inc.
VIE
|
5.37 B |
- |
- |
$ 2.91 B |
USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M |
- |
- |
$ 10.1 M |
USA |
 |
Aphria Inc.
APHA
|
54.3 B |
- |
-0.45 % |
$ 4.87 B |
Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
3.74 B |
- |
-0.90 % |
$ 104 M |
USA |